ARCHIVES

FDA Designates Zometa For Priority Review.

This article is from The Cancer Letter archive.

Vol. 27 No. 44 | November 30, 2001

Download PDF Visit The Full Archive

Related Articles

Smokeless Tobacco Warning Bill May Go To House Floor

January 24, 1986

CMS To Recognize NCCN’s Drug Compendium.

June 6, 2008

Rauscher Tabs Oak Ridge Immunologists To Head Basic Research At Frederick

August 30, 1974

Lilly Made False Claims About Ralozifene Reducing Breast Cancer risk, Judge Rules

July 30, 1999

Cancer Letter Skips Next Two Weeks

September 2, 1988

Shift Towards More Treatable AIDS Lymphomas Identified

July 25, 2003